| Name | Title | Contact Details |
|---|
Medgenics is a clinical-stage biopharmaceutical company developing an innovative and proprietary platform technology - a biological "Biopump" - which allows patients to produce, within their bodies and on a long-term basis, their own natural human protein therapy for the treatment of a range of chronic diseases, such as anemia and hepatitis C.
EKR Therapeutics, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bedminster, NJ. To find more information about EKR Therapeutics, Inc., please visit www.ekrtx.com
Healthcare Anchor Network is a collaboration of over 65 healthcare systems in the United States that are committed to leveraging their institutional assets to improve health and well-being by addressing economic and racial inequities in the communities...
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.
Hugh Chatham Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Hugh Chatham Memorial Hospital is based in Elkin, NC. You can find more information on Hugh Chatham Memorial Hospital at www.hughchatham.org